• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国高血压患者合并症的患病率及危险因素

Prevalence and Risk Factors of Comorbidities among Hypertensive Patients in China.

作者信息

Wang Jiaojiao, Ma Jian James, Liu Jiaqi, Zeng Daniel Dajun, Song Cynthia, Cao Zhidong

机构信息

The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China.

College of Business, University of Colorado, Colorado Springs, CO, USA.

出版信息

Int J Med Sci. 2017 Feb 23;14(3):201-212. doi: 10.7150/ijms.16974. eCollection 2017.

DOI:10.7150/ijms.16974
PMID:28367080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5370282/
Abstract

Hypertension is a severe threat to human being's health due to its association with many comorbidities. Many research works have explored hypertension's prevalence and treatment. However, few considered impact of patient's socioeconomic status and geographical disparities. We intended to fulfill that research gap by analyzing the association of the prevalence of hypertension and three important comorbidities with various socioeconomic and geographical factors. We also investigated the prevalence of those comorbidities if the patient has been diagnosed with hypertension. We obtained a large collection of medical records from 29 hospitals across China. We utilized Bayes' Theorem, Pearson's chi-squared test, univariate and multivariate regression methods and geographical detector methods to analyze the association between disease prevalence and risk factors. We first attempted to quantified and analyzed the spatial stratified heterogeneity of the prevalence of hypertension comorbidities by q-statistic using geographical detector methods. We found that the demographic and socioeconomic factors, and hospital class and geographical factors would have an enhanced interactive influence on the prevalence of hypertension comorbidities. Our findings can be leveraged by public health policy makers to allocate medical resources more effectively. Healthcare practitioners can also be benefited by our analysis to offer customized disease prevention for populations with different socioeconomic status.

摘要

高血压因其与许多合并症相关联,对人类健康构成严重威胁。许多研究工作都探讨了高血压的患病率及治疗方法。然而,很少有研究考虑患者社会经济地位和地域差异的影响。我们旨在通过分析高血压患病率及三种重要合并症与各种社会经济和地理因素之间的关联来填补这一研究空白。我们还调查了已被诊断患有高血压的患者中这些合并症的患病率。我们从中国各地的29家医院收集了大量病历。我们运用贝叶斯定理、皮尔逊卡方检验、单变量和多变量回归方法以及地理探测器方法来分析疾病患病率与风险因素之间的关联。我们首先尝试使用地理探测器方法通过q统计量对高血压合并症患病率的空间分层异质性进行量化和分析。我们发现人口统计学和社会经济因素、医院等级和地理因素对高血压合并症患病率会产生增强的交互影响。我们的研究结果可供公共卫生政策制定者更有效地分配医疗资源。医疗从业者也可从我们的分析中受益,为不同社会经济地位的人群提供定制化的疾病预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b9/5370282/50fc0f5224c5/ijmsv14p0201g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b9/5370282/eef86128e2f1/ijmsv14p0201g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b9/5370282/50fc0f5224c5/ijmsv14p0201g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b9/5370282/eef86128e2f1/ijmsv14p0201g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b9/5370282/50fc0f5224c5/ijmsv14p0201g002.jpg

相似文献

1
Prevalence and Risk Factors of Comorbidities among Hypertensive Patients in China.中国高血压患者合并症的患病率及危险因素
Int J Med Sci. 2017 Feb 23;14(3):201-212. doi: 10.7150/ijms.16974. eCollection 2017.
2
Comorbidity Analysis According to Sex and Age in Hypertension Patients in China.中国高血压患者按性别和年龄的合并症分析
Int J Med Sci. 2016 Jan 29;13(2):99-107. doi: 10.7150/ijms.13456. eCollection 2016.
3
Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey.中国高血压患病率、知晓率、治疗率和控制率的地域差异:一项全国和省级代表性调查的结果。
J Hypertens. 2018 Jan;36(1):178-187. doi: 10.1097/HJH.0000000000001531.
4
Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007.2004年至2007年中国广东省居民高血压的患病率、知晓率、治疗率和控制率
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):217-22. doi: 10.1161/CIRCOUTCOMES.111.000062. Epub 2013 Mar 12.
5
Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006.伊朗高血压的流行率、治疗和控制方面的社会差异:2006 年第二次非传染性疾病危险因素国家监测。
J Hypertens. 2010 Aug;28(8):1620-9. doi: 10.1097/HJH.0b013e32833a38f2.
6
Comorbidity in Adult Patients Hospitalized with Type 2 Diabetes in Northeast China: An Analysis of Hospital Discharge Data from 2002 to 2013.中国东北地区2型糖尿病成年住院患者的合并症:基于2002年至2013年出院数据的分析
Biomed Res Int. 2016;2016:1671965. doi: 10.1155/2016/1671965. Epub 2016 Oct 25.
7
Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.高血压患者心房颤动的患病率及相关因素:一项全国性研究。
BMC Cardiovasc Disord. 2016 Mar 22;16:57. doi: 10.1186/s12872-016-0232-4.
8
Refining hypertension surveillance to account for potentially misclassified cases.完善高血压监测以考虑可能被误分类的病例。
PLoS One. 2015 Mar 24;10(3):e0119186. doi: 10.1371/journal.pone.0119186. eCollection 2015.
9
Ankle-brachial index is lower in hypertensive than in normotensive individuals in a cardiovascular risk population.在心血管风险人群中,高血压患者的踝臂指数低于血压正常者。
J Hypertens. 2009 Oct;27(10):2036-43. doi: 10.1097/HJH.0b013e32832f4f54.
10
Geographical differences in blood pressure of male youth aged 17-21 years in China.中国17至21岁男性青年血压的地域差异。
Blood Press. 2004;13(3):169-75. doi: 10.1080/08037050410035545.

引用本文的文献

1
Predictors of blood pressure control among patients with hypertension: a cross-sectional study in a Nigerian tertiary health facility.高血压患者血压控制的预测因素:尼日利亚一家三级医疗机构的横断面研究
BMJ Open. 2025 Mar 18;15(3):e091010. doi: 10.1136/bmjopen-2024-091010.
2
Apolipoprotein E E3/E4 genotype is associated with an increased risk of coronary atherosclerosis in patients with hypertension.载脂蛋白 E E3/E4 基因型与高血压患者冠状动脉粥样硬化的风险增加相关。
BMC Cardiovasc Disord. 2024 Sep 12;24(1):486. doi: 10.1186/s12872-024-04169-3.
3
A tryst of 'blood pressure control- sex- comorbidities': the odyssey of basic public health services in Yunnan in quest for truth.

本文引用的文献

1
Comorbidity Analysis According to Sex and Age in Hypertension Patients in China.中国高血压患者按性别和年龄的合并症分析
Int J Med Sci. 2016 Jan 29;13(2):99-107. doi: 10.7150/ijms.13456. eCollection 2016.
2
Lifestyle and Risk of Hypertension: Follow-Up of a Young Pre-Hypertensive Cohort.生活方式与高血压风险:年轻高血压前期队列的随访研究
Int J Med Sci. 2015 Jul 16;12(7):605-12. doi: 10.7150/ijms.12446. eCollection 2015.
3
Fruit and vegetable consumption and cardiovascular risk factors in older Chinese: the Guangzhou biobank cohort study.
一场关于“血压控制-性生活-共病”的幽会:云南基本公共卫生服务探寻真相的征程。
BMC Public Health. 2024 Feb 16;24(1):490. doi: 10.1186/s12889-023-17157-7.
4
Association Between Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients.高血压患者基因多态性与糖尿病风险的关联
Int J Gen Med. 2023 Dec 6;16:5719-5727. doi: 10.2147/IJGM.S435598. eCollection 2023.
5
E2/E3 and E3/E4 Genotypes of the Apolipoprotein E are Associated with Higher Risk of Diabetes Mellitus in Patients with Hypertension.载脂蛋白E的E2/E3和E3/E4基因型与高血压患者患糖尿病的较高风险相关。
Int J Gen Med. 2023 Nov 24;16:5579-5586. doi: 10.2147/IJGM.S438008. eCollection 2023.
6
Regional disparities and influencing factors of high quality medical resources distribution in China.中国优质医疗资源分布的区域差异及影响因素。
Int J Equity Health. 2023 Jan 10;22(1):8. doi: 10.1186/s12939-023-01825-6.
7
Effects of Aerobic Training Progression on Blood Pressure in Individuals With Hypertension: A Systematic Review With Meta-Analysis and Meta-Regression.有氧运动训练进展对高血压患者血压的影响:一项荟萃分析和元回归的系统评价
Front Sports Act Living. 2022 Feb 17;4:719063. doi: 10.3389/fspor.2022.719063. eCollection 2022.
8
Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study.安罗替尼单药作为老年非小细胞肺癌三线治疗的疗效和安全性:一项真实世界探索性研究
Int J Gen Med. 2021 Nov 2;14:7625-7637. doi: 10.2147/IJGM.S334436. eCollection 2021.
9
Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome.硫氰酸芥子碱通过抑制NLRP3炎性小体的激活改善高血压患者的血管内皮功能障碍。
Front Pharmacol. 2021 Feb 9;11:620159. doi: 10.3389/fphar.2020.620159. eCollection 2020.
10
Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study.高血压与血压正常的 COVID-19 有症状患者的患病率、临床表现和生化数据:一项比较研究。
Acta Biomed. 2020 Nov 10;91(4):e2020164. doi: 10.23750/abm.v91i4.10540.
中国老年人的水果和蔬菜摄入量与心血管危险因素:广州生物银行队列研究
PLoS One. 2015 Aug 10;10(8):e0135380. doi: 10.1371/journal.pone.0135380. eCollection 2015.
4
The food retail revolution in China and its association with diet and health.中国的食品零售革命及其与饮食和健康的关联。
Food Policy. 2015 Aug 1;55:92-100. doi: 10.1016/j.foodpol.2015.07.001.
5
High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors.中国西北部中老年人群维生素D缺乏的高患病率:其与骨质疏松症及生活方式因素的关系。
Bone. 2015 Feb;71:1-6. doi: 10.1016/j.bone.2014.09.024. Epub 2014 Oct 5.
6
Heart failure: gaps in knowledge and failures in treatment.心力衰竭:知识空白与治疗失败
PLoS Med. 2014 Aug 12;11(8):e1001702. doi: 10.1371/journal.pmed.1001702. eCollection 2014 Aug.
7
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis.低收入和中等收入国家的心力衰竭护理:系统评价与荟萃分析
PLoS Med. 2014 Aug 12;11(8):e1001699. doi: 10.1371/journal.pmed.1001699. eCollection 2014 Aug.
8
Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences.中国高血压患病率:趋势和地区差异的系统评价与meta回归分析
J Hypertens. 2014 Oct;32(10):1919-27; discussion 1927. doi: 10.1097/HJH.0000000000000252.
9
Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study.高脂血症、他汀类药物使用与患抑郁症风险:一项全国性回顾性队列研究。
Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):497-501. doi: 10.1016/j.genhosppsych.2014.05.008. Epub 2014 May 17.
10
Indigenous plant medicines for health care: treatment of Diabetes mellitus and hyperlipidemia.本土植物药在医疗保健中的应用:治疗糖尿病和高血脂。
Chin J Nat Med. 2014 May;12(5):335-44. doi: 10.1016/S1875-5364(14)60041-8.